Takeda and TRIANNI Sign Licensing Agreement For Use of TRIANNI Transgenic Mouse Platform

TRIANNI, Inc. (“Trianni”) and Takeda Pharmaceutical Company Limited (“Takeda”) jointly announced today that they have entered into a license agreement […]

Continue reading

TRIANNI Announces Launch of Its Optimized Human Antibody Transgenic Mouse

Emeryville, California – TRIANNI, Inc., a Californian biotechnology company, announced today the launch of its TRIANNI Mouse, a monoclonal antibody […]

Continue reading